UNSPSC 51142524: Doreptide

This classification denotes an antiparkinsonian agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 51K3U6Q5ZN. European Medicines Agency schedules Doreptide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06371MIG. Doreptide generally arises in the molecular formula C17H24N4O3.

UNSPSC 51142524 Doreptide is a Commodity code that covers pharmaceutical products and drug-deactivation systems procured by state and local health agencies to support community health and public safety initiatives. The code captures goods such as naloxone (opioid overdose reversal medication) and safe drug deactivation or disposal systems purchased for emergency response, harm reduction, and controlled-substance management programs. State and local health departments and county community health agencies are the primary issuing bodies under this code, soliciting through competitive bidding processes (IFB) with standard compliance requirements including drug-free workplace certification, E-Verify employment verification, and insurance coverage mandates.

Recent activity centers in Florida, where Seminole County posted IFB 60459723LAS in June 2026 seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The solicitation closed July 26, 2023, with contracts structured as fixed-fee awards on an initial two-year term plus one-year renewal option; vendors were required to include all shipping and delivery costs in their proposals and comply with potential FEMA funding conditions, including adherence to the Clean Air Act and Federal Water Pollution Control Act. The procurement showed no explicit set-aside or disadvantaged-enterprise restrictions.